Generis Farmacêutica SA in Consumer Health (Portugal)

September 2016 | 2 pages | ID: G4E4B64458FEN
Euromonitor International Ltd

Abstracts

Generis is expected to continue to focus on the production and distribution of generic medicines of products reaching the end of their life cycle or which have already lost their patent. It will therefore aim to produce the same quality products as the original, but at a lower price, and gain volume share.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
  Summary 1 Generis Farmacêutica SA: Key Facts
  Summary 2 Generis Farmacêutica SA: Operational Indicators
Competitive Positioning
  Summary 3 Generis Farmacêutica SA: Competitive Position 2016